Drawing for LONZA

USPTO serial 86138751

LONZA

Reviewed by CopyMark Law Group

Reg. 4639815Status 800Registered
Filing date
Status date
Registration date
Nov 18, 2014
Examiner
DAWE III, WILLIAM H
Law office
—

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with LONZA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence J. Crain

Lawrence J. Crain Greer, Burns & Crain, Ltd.300 South Wacker DriveSuite 2500Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
001chemicals for use in industry and science; [ chemicals for use in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; manures; tempering preparations and soldering chemicals and fluxes; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; ] inorganic and organic salts, namely, carnitine salts and l-carnitine salts; acids, namely, protein and nucleic acids for detection purposes other than for medical and veterinary purposes, docosahexaenoic acids, omega-3 fatty acids and derivatives thereof, [ carboxylic acid, halogenated fatty acids for industrial, manufacturing, or chemical use, and hydroxyacids; saturated and unsaturated aliphatic hydrocarbons; paraffin; aromatic hydrocarbons; organic oxygen compounds, namely, monovalent and multivalent alcoholates, esters, ketones, aldehydes, ethers, anhydrides, and keto compounds; nitrogen compounds, namely, nitrides, nitriles, amines, and amides; cyclic compounds, namely, heterocyclic compounds and compounds containing heteroatoms; carbides; oxides; silicides; borides; phosphates; phosphines; silicates; inorganic compounds containing halogen and sulphur; catalysts for chemical and biochemical processes; aromatic solvents for industrial and commercial use; fire extinguishing and fire retardant compositions; bleaching preparations for industrial purposes; surface active compounds for general use in the industrial arts, namely, emulsifying agents; wetting agents; chemical compound for use as an antimicrobial agent in the manufacture of household, institutional and industrial cleaners, deodorizers, water based paints and stains, and hydraulic fluids; chemical compounds and additives for use in the manufacture of wood preservatives; chemicals for the treatment of wood, namely, chemicals for the prevention of sap stain; chemical compounds for use in the manufacturing of household and industrial disinfectants and sanitizers; ] carnitine and its salts and derivates for use in the production of pharmaceutical preparations, dietetic substances and foodstuffs; chemical preparations and reagents for scientific purposes, namely, isolated human and animal cells cryopreserved and in culture for research purposes; diagnostic reagents for biological and pharmaceutical research and chemical reagents for non-medical purposes, namely, the manufacture of pharmaceutical products; endotoxin detection products, namely, assays and reagents for use in pharmaceutical and biotech research; diagnostic reagents for clinical or medical laboratory use; electrophoresis supplies, namely, nucleic acid stains, DNA markers, and loading buffers for non-medical use, electrophoresis gels other than for medical or veterinary purposes [ ; active chemical ingredients for use in the manufacture of personal care products, namely, hair and skin moisturizing and conditioning agents; chemicals for the treatment of water and wastewater; water treatment chemicals for use in swimming pools and spas ]ACTIVE—
002[ dyes for textile fabrics; paints; varnishes; lacquers; preservatives against rust in the nature of a coating; anti-corrosive and anti-fouling compositions, namely, paints and coatings; anti-corrosive oils; chemical wood preservatives to prevent decay, deterioration, insect damage and rot; wood preservatives; colorants; raw natural resins; wood stains; enamel paints; distempers; priming preparations and base coats, namely, paints; coating preparations having water repellant properties; waterproof paints; coatings for wood as paints ]SECTION 8 - CANCELLED—
005[ antimicrobial preservatives for cosmetics and pharmaceuticals; ] pharmaceutical and veterinary preparations for the treatment of genetic malfunction in gene therapy, viral and infectious diseases, cardiovascular diseases, lung diseases, neurological diseases, and cancer; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; food for babies; dietary supplements for humans and animals; medical plasters; bandages for dressings; medical dressings; all purpose disinfectants; [ disinfectants for hygienic and sanitary purposes; multi-purpose disinfectants for household, institutional and industrial use; antimicrobial preservatives for use in the manufacture of cosmetics and toiletries; preparations for destroying vermin; fungicides; herbicides; preparations for killing weeds; insecticides; pesticides; bactericides; germicides; algaecides; preparations for destroying snails and mollusks; ] cell culture media for medical or clinical use and for scientific research, namely, for cultivating human cells, animal cells, and plant cells; antitoxic sera; sera and reagents for biological and pharmaceutical research and for the manufacture of pharmaceutical products; serum-free cell growth media for medical or clinical use; cell culture reagents for medical or clinical use; endotoxin detection assays and reagents for medical or clinical use; deodorizers and sanitizers for industrial and household use; l-carnitine, salts, and derivatives thereof for pharmaceutical use, namely, for the treatment or prevention of cardiovascular diseases, cancer diseases, kidney diseases, diseases and disorders of fat and glucose metabolism, primary and secondary l-carnitine deficiency, male infertility, mental and cognitive diseases, liver diseases, HIV and AIDS, trauma and sepsis, malnutrition, aging and bone loss, or as ingredients of pharmaceutical preparations; l-carnitine, salts and derivatives thereof as dietetic substances adapted for medical use and foodstuffs for medical use; dietary supplements and preparations for treating colds; algaecides, bactericides and virucides for use in recirculating water systems, swimming pools and spas; antiseptics for human and veterinary useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 10, 2024NP89NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED—
Dec 10, 2024RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Dec 10, 20249G8PREGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8—
Dec 10, 20248PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED—
Dec 10, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 3, 2024E89RTEAS SECTION 8 & 9 RECEIVED—
Nov 18, 2023REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Nov 18, 2020NOSUNOTICE OF SUIT—
Feb 4, 2020NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Feb 4, 2020C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 3, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 6, 2019E815TEAS SECTION 8 & 15 RECEIVED—
Nov 18, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 24, 2017NOSUNOTICE OF SUIT—
Apr 24, 2017NOSUNOTICE OF SUIT—
Sep 2, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 2, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 17, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 18, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 2, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 2, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 13, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 29, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 29, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 24, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 23, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 2, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 2, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 2, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 3, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 20, 2014ALIEASSIGNED TO LIE—
May 7, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 19, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2014DOCKASSIGNED TO EXAMINER—
Dec 21, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 12, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance